Showing results (881-890 of 9,668) with videos related to
Sort By:
Pageof 967
Leukemia|June 1, 1988
The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension cultureJ Miyauchi, C A Kelleher, G G Wong, et al.Leukemia|September 29, 2016
B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemiaG Galletti, F Caligaris-Cappio, M T S BertilaccioLeukemia|December 29, 2016
Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptorsI Aldoss, R C Bargou, D Nagorsen, et al.Leukemia|March 22, 2017
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated componentsF Pozzo, T Bittolo, E Vendramini, et al.Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.Leukemia|March 22, 2017
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaA-K Eisfeld, K Mrózek, J Kohlschmidt, et al.Leukemia|March 24, 2017
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALLA M Savino, J Sarno, L Trentin, et al.Leukemia|March 25, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trialsG Montalban-Bravo, X Huang, K Naqvi, et al.Leukemia|April 8, 2017
Measurable residual disease testing in acute myeloid leukaemiaC S Hourigan, R P Gale, N J Gormley, et al.Leukemia|April 8, 2017
Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosisT Maekawa, Y Osawa, T Izumi, et al.Pageof 967